Clinical Trial Update: The Efficacy of 10-day and 14-day Bismuth-based Quadruple Therapy in First-line H. Pylori Eradication [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial is evaluating the efficacy of 10-day versus 14-day bismuth-based quadruple therapy as first-line treatment for Helicobacter pylori i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Snippet

Sponsor: National Cheng-Kung University Hospital | Conditions: Helicobacter Pylori Infection, Dysbiosis | Phase 4 | Status: ENROLLING_BY_INVITATION